A bill to amend the Controlled Substances Act to require identification by manufacturer of each schedule II dosage unit produced.
Dangerous Drug Identification Act - Requires that each solid oral form dosage unit carry a manufacturer's identification as required by regulation of the Attorney General.
Referred to House Committee on Interstate and Foreign Commerce.
Introduced in House
Introduced in House
Referred to House Committee on Interstate and Foreign Commerce.
checking server…
Ask anything about this bill. The AI reads the full text to answer.
Enter to send · Shift+Enter for new line